Heron Net Receivables vs Cash And Short Term Investments Analysis

HRTX Stock

USD 3.44 0.03 0.86%

Heron Therapeuti financial indicator trend analysis is much more than just examining Heron Therapeuti latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Heron Therapeuti is a good investment. Please check the relationship between Heron Therapeuti Net Receivables and its Cash And Short Term Investments accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Heron Therapeuti. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.

For more information on how to buy Heron Stock please use our How to Invest in Heron Therapeuti guide.

Net Receivables vs Cash And Short Term Investments

Net Receivables vs Cash And Short Term Investments Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Heron Therapeuti Net Receivables account and Cash And Short Term Investments. At this time, the significance of the direction appears to have fragmental relationship.

The correlation between Heron Therapeuti's Net Receivables and Cash And Short Term Investments is 0.5. Overlapping area represents the amount of variation of Net Receivables that can explain the historical movement of Cash And Short Term Investments in the same time period over historical financial statements of Heron Therapeuti, assuming nothing else is changed. The correlation between historical values of Heron Therapeuti's Net Receivables and Cash And Short Term Investments is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Receivables of Heron Therapeuti are associated (or correlated) with its Cash And Short Term Investments. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cash And Short Term Investments has no effect on the direction of Net Receivables i.e., Heron Therapeuti's Net Receivables and Cash And Short Term Investments go up and down completely randomly.

Correlation Coefficient

0.5

Relationship Direction	Positive
Relationship Strength	Weak

View All Relationships

Net Receivables

Cash And Short Term Investments

Short Term Investments is an account in the current assets section of Heron Therapeuti balance sheet. This account contains Heron Therapeuti investments that will expire within one year. These investments include stocks and bonds that can be liquidated by Heron Therapeuti fairly quickly. The sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash.

Most indicators from Heron Therapeuti's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Heron Therapeuti current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Heron Therapeuti. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.

For more information on how to buy Heron Stock please use our How to Invest in Heron Therapeuti guide.At this time, Heron Therapeuti's Selling General Administrative is fairly stable compared to the past year. Discontinued Operations is likely to rise to about 1.3 M in 2024, whereas Issuance Of Capital Stock is likely to drop slightly above 28.3 M in 2024.

	2021	2022	2023	2024 (projected)
Total Operating Expenses	258.2M	227.5M	172.6M	181.2M
Cost Of Revenue	46.0M	54.9M	65.1M	68.4M

Total Operating Expenses Cost Of Revenue

Heron Therapeuti fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Inventory	Other Current Assets	Accounts Payable	Common Stock Total Equity	Common Stock	Other Liab
Total Assets		0.23	0.87	0.86	0.78	0.76	0.07	-0.65	0.28	0.66	0.23	0.91	0.78	0.64	0.0	0.77	0.5	0.66	1.0	0.35	0.71	0.87	0.35	-0.09	-0.06	-0.7
Short Long Term Debt Total	0.23		0.58	0.48	-0.42	0.62	0.91	-0.86	-0.23	0.77	0.87	-0.15	0.64	0.85	0.93	0.77	0.95	0.77	0.15	-0.06	0.77	0.2	-0.09	0.0	0.22	-0.52
Other Current Liab	0.87	0.58		0.96	0.42	0.91	0.4	-0.9	0.17	0.85	0.47	0.63	0.91	0.89	0.33	0.96	0.8	0.89	0.84	0.37	0.9	0.83	0.23	-0.09	0.03	-0.81
Total Current Liabilities	0.86	0.48	0.96		0.46	0.78	0.25	-0.81	0.32	0.72	0.36	0.66	0.9	0.81	0.18	0.88	0.73	0.75	0.84	0.6	0.8	0.75	0.46	-0.12	-0.03	-0.8
Total Stockholder Equity	0.78	-0.42	0.42	0.46		0.31	-0.51	-0.04	0.39	0.13	-0.32	0.95	0.29	0.04	-0.57	0.21	-0.15	0.11	0.83	0.31	0.16	0.67	0.34	-0.07	-0.19	-0.31
Property Plant And Equipment Net	0.76	0.62	0.91	0.78	0.31		0.46	-0.88	0.11	0.97	0.6	0.49	0.75	0.84	0.44	0.91	0.78	0.94	0.7	0.11	0.9	0.87	-0.14	-0.02	0.09	-0.75
Net Debt	0.07	0.91	0.4	0.25	-0.51	0.46		-0.7	-0.61	0.6	0.77	-0.29	0.51	0.7	0.89	0.6	0.81	0.63	0.0	-0.36	0.65	0.06	-0.2	0.05	0.27	-0.37
Retained Earnings	-0.65	-0.86	-0.9	-0.81	-0.04	-0.88	-0.7		0.0	-0.92	-0.74	-0.3	-0.88	-0.98	-0.7	-0.98	-0.97	-0.94	-0.58	-0.16	-0.95	-0.62	-0.06	0.03	-0.15	0.72
Cash	0.28	-0.23	0.17	0.32	0.39	0.11	-0.61	0.0		0.04	-0.14	0.39	0.03	-0.02	-0.32	0.06	-0.09	-0.01	0.3	0.72	-0.06	0.25	0.3	-0.12	-0.21	-0.11
Non Current Assets Total	0.66	0.77	0.85	0.72	0.13	0.97	0.6	-0.92	0.04		0.79	0.34	0.74	0.86	0.61	0.91	0.87	0.92	0.59	0.04	0.93	0.75	-0.15	0.01	0.13	-0.73
Non Currrent Assets Other	0.23	0.87	0.47	0.36	-0.32	0.6	0.77	-0.74	-0.14	0.79		-0.1	0.49	0.67	0.84	0.66	0.81	0.62	0.15	-0.15	0.75	0.28	-0.14	0.06	0.18	-0.47
Cash And Short Term Investments	0.91	-0.15	0.63	0.66	0.95	0.49	-0.29	-0.3	0.39	0.34	-0.1		0.5	0.3	-0.35	0.46	0.13	0.33	0.94	0.38	0.37	0.77	0.42	-0.11	-0.17	-0.46
Net Receivables	0.78	0.64	0.91	0.9	0.29	0.75	0.51	-0.88	0.03	0.74	0.49	0.5		0.9	0.41	0.91	0.83	0.81	0.75	0.35	0.89	0.58	0.39	-0.04	0.13	-0.83
Common Stock Shares Outstanding	0.64	0.85	0.89	0.81	0.04	0.84	0.7	-0.98	-0.02	0.86	0.67	0.3	0.9		0.69	0.98	0.96	0.94	0.59	0.16	0.91	0.56	0.08	-0.07	0.15	-0.7
Non Current Liabilities Total	0.0	0.93	0.33	0.18	-0.57	0.44	0.89	-0.7	-0.32	0.61	0.84	-0.35	0.41	0.69		0.58	0.79	0.61	-0.08	-0.31	0.59	0.0	-0.29	0.11	0.33	-0.22
Other Stockholder Equity	0.77	0.77	0.96	0.88	0.21	0.91	0.6	-0.98	0.06	0.91	0.66	0.46	0.91	0.98	0.58		0.92	0.94	0.71	0.21	0.95	0.71	0.11	-0.05	0.12	-0.75
Total Liab	0.5	0.95	0.8	0.73	-0.15	0.78	0.81	-0.97	-0.09	0.87	0.81	0.13	0.83	0.96	0.79	0.92		0.88	0.43	0.13	0.9	0.45	0.08	-0.04	0.17	-0.69
Property Plant And Equipment Gross	0.66	0.77	0.89	0.75	0.11	0.94	0.63	-0.94	-0.01	0.92	0.62	0.33	0.81	0.94	0.61	0.94	0.88		0.59	0.06	0.89	0.68	-0.16	-0.01	0.18	-0.73
Total Current Assets	1.0	0.15	0.84	0.84	0.83	0.7	0.0	-0.58	0.3	0.59	0.15	0.94	0.75	0.59	-0.08	0.71	0.43	0.59		0.38	0.64	0.84	0.4	-0.09	-0.08	-0.67
Short Term Debt	0.35	-0.06	0.37	0.6	0.31	0.11	-0.36	-0.16	0.72	0.04	-0.15	0.38	0.35	0.16	-0.31	0.21	0.13	0.06	0.38		0.08	0.22	0.68	-0.15	-0.17	-0.4
Inventory	0.71	0.77	0.9	0.8	0.16	0.9	0.65	-0.95	-0.06	0.93	0.75	0.37	0.89	0.91	0.59	0.95	0.9	0.89	0.64	0.08		0.68	0.08	0.01	0.15	-0.77
Other Current Assets	0.87	0.2	0.83	0.75	0.67	0.87	0.06	-0.62	0.25	0.75	0.28	0.77	0.58	0.56	0.0	0.71	0.45	0.68	0.84	0.22	0.68		0.0	-0.03	-0.05	-0.61
Accounts Payable	0.35	-0.09	0.23	0.46	0.34	-0.14	-0.2	-0.06	0.3	-0.15	-0.14	0.42	0.39	0.08	-0.29	0.11	0.08	-0.16	0.4	0.68	0.08	0.0		-0.17	-0.2	-0.25
Common Stock Total Equity	-0.09	0.0	-0.09	-0.12	-0.07	-0.02	0.05	0.03	-0.12	0.01	0.06	-0.11	-0.04	-0.07	0.11	-0.05	-0.04	-0.01	-0.09	-0.15	0.01	-0.03	-0.17		0.95	0.16
Common Stock	-0.06	0.22	0.03	-0.03	-0.19	0.09	0.27	-0.15	-0.21	0.13	0.18	-0.17	0.13	0.15	0.33	0.12	0.17	0.18	-0.08	-0.17	0.15	-0.05	-0.2	0.95		0.05
Other Liab	-0.7	-0.52	-0.81	-0.8	-0.31	-0.75	-0.37	0.72	-0.11	-0.73	-0.47	-0.46	-0.83	-0.7	-0.22	-0.75	-0.69	-0.73	-0.67	-0.4	-0.77	-0.61	-0.25	0.16	0.05

Click cells to compare fundamentals

Heron Therapeuti Account Relationship Matchups

Heron Therapeuti fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	512.8M	353.6M	305.7M	251.0M	222.5M	233.6M
Short Long Term Debt Total	19.8M	24.6M	159.5M	157.5M	179.6M	188.6M
Other Current Liab	86.4M	91.9M	64.8M	76.4M	73.4M	77.0M
Total Current Liabilities	96.7M	102.5M	71.1M	82.4M	79.7M	83.7M
Total Stockholder Equity	403.8M	236.5M	77.6M	13.6M	(34.0M)	(32.3M)
Property Plant And Equipment Net	33.4M	39.0M	33.6M	29.8M	25.6M	26.9M
Net Debt	(52.1M)	(80.5M)	69.0M	142.1M	151.0M	158.5M
Retained Earnings	(1.2B)	(1.4B)	(1.6B)	(1.8B)	(1.9B)	(1.8B)
Cash	71.9M	105.1M	90.5M	15.4M	28.7M	27.8M
Non Current Assets Total	33.7M	39.4M	51.3M	45.5M	33.7M	35.4M
Cash And Short Term Investments	391.0M	208.5M	157.6M	84.9M	80.4M	60.9M
Net Receivables	39.9M	41.9M	35.5M	52.0M	60.1M	63.1M
Common Stock Shares Outstanding	81.8M	90.8M	98.5M	108.9M	138.1M	145.0M
Liabilities And Stockholders Equity	512.8M	353.6M	305.7M	251.0M	222.5M	233.6M
Non Current Liabilities Total	12.2M	14.6M	157.1M	155.0M	176.8M	185.6M
Other Stockholder Equity	1.6B	1.6B	1.7B	1.8B	1.9B	2.0B
Total Liab	108.9M	117.1M	228.1M	237.4M	256.5M	269.3M
Property Plant And Equipment Gross	33.4M	39.0M	33.6M	29.8M	42.6M	44.8M
Total Current Assets	479.1M	314.2M	254.4M	205.4M	188.8M	198.2M
Accumulated Other Comprehensive Income	85K	257K	(6K)	(19K)	13K	13.7K
Short Term Debt	7.6M	10.1M	2.4M	2.7M	3.1M	3.5M
Inventory	25.0M	41.9M	48.4M	54.6M	42.1M	44.2M
Other Current Assets	23.2M	22.0M	13.0M	14.0M	6.1M	4.4M
Accounts Payable	2.8M	525K	3.8M	3.2M	3.2M	3.2M
Common Stock Total Equity	782K	903K	913K	1.0M	1.2M	658.0K
Common Stock	903K	913K	1.0M	1.2M	1.5M	1.6M
Other Assets	346K	16.6M	17.7M	15.7M	18.1M	19.0M
Short Term Investments	319.1M	103.4M	67.0M	69.5M	51.7M	55.8M
Property Plant Equipment	19.6M	22.7M	33.6M	29.8M	34.3M	36.0M
Net Tangible Assets	403.8M	236.5M	77.6M	13.6M	15.6M	14.8M
Retained Earnings Total Equity	(960.7M)	(1.2B)	(1.4B)	(1.6B)	(1.5B)	(1.4B)
Capital Surpluse	1.3B	1.6B	1.6B	1.7B	1.9B	2.0B
Short Long Term Debt	28.7M	4.6M	5.6M	7.1M	8.1M	8.3M
Net Invested Capital	409.5M	243.5M	226.7M	162.9M	139.8M	196.2M
Net Working Capital	382.4M	211.7M	183.4M	123.1M	109.1M	170.3M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

DD	Dupont De Nemours
GM	General Motors
BAC	Bank of America

When determining whether Heron Therapeuti offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Heron Therapeuti's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Heron Therapeuti Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Heron Therapeuti Stock:

How To Invest In Heron

Details

Is Heron Stock a good investment?

Details

What is Heron Therapeuti's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Heron Therapeuti. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.

For more information on how to buy Heron Stock please use our How to Invest in Heron Therapeuti guide.

You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Complementary Tools for Heron Stock analysis

When running Heron Therapeuti's price analysis, check to measure Heron Therapeuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heron Therapeuti is operating at the current time. Most of Heron Therapeuti's value examination focuses on studying past and present price action to predict the probability of Heron Therapeuti's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heron Therapeuti's price. Additionally, you may evaluate how the addition of Heron Therapeuti to your portfolios can decrease your overall portfolio volatility.

	Insider Screener Find insiders across different sectors to evaluate their impact on performance
	Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
	CEOs Directory Screen CEOs from public companies around the world
	Global Correlations Find global opportunities by holding instruments from different markets
	Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
	Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market.
	Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings
	Commodity Directory Find actively traded commodities issued by global exchanges
	Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
	Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities
	Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
	Economic Indicators Top statistical indicators that provide insights into how an economy is performing

Is Heron Therapeuti's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Heron Therapeuti. If investors know Heron will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Heron Therapeuti listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.55)

Revenue Per Share

0.904

Quarterly Revenue Growth

0.171

Return On Assets

(0.18)

Return On Equity

(24.09)

The market value of Heron Therapeuti is measured differently than its book value, which is the value of Heron that is recorded on the company's balance sheet. Investors also form their own opinion of Heron Therapeuti's value that differs from its market value or its book value, called intrinsic value, which is Heron Therapeuti's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Heron Therapeuti's market value can be influenced by many factors that don't directly affect Heron Therapeuti's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Heron Therapeuti's value and its price as these two are different measures arrived at by different means. Investors typically determine if Heron Therapeuti is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Heron Therapeuti's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Heron Net Receivables vs Cash And Short Term Investments Analysis

Net Receivables vs Cash And Short Term Investments

Net Receivables vs Cash And Short Term Investments Correlation Analysis

Correlation Coefficient

Net Receivables

Cash And Short Term Investments

Heron Therapeuti fundamental ratios Correlations

Heron Therapeuti Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Heron Therapeuti fundamental ratios Accounts

Also Currently Popular

Complementary Tools for Heron Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 1.0	Total Assets
Other Stockholder Equity	+ 0.98	Common Stock Shares Outstanding
Non Current Assets Total	+ 0.97	Property Plant And Equipment Net
Total Current Liabilities	+ 0.96	Other Current Liab
Other Stockholder Equity	+ 0.96	Other Current Liab
Total Liab	+ 0.96	Common Stock Shares Outstanding

Other Stockholder Equity	- 0.98	Retained Earnings
Common Stock Shares Outstanding	- 0.98	Retained Earnings
Total Liab	- 0.97	Retained Earnings
Inventory	- 0.95	Retained Earnings
Property Plant And Equipment Gross	- 0.94	Retained Earnings
Non Current Assets Total	- 0.92	Retained Earnings